litlas
ログインアカウント作成

Mark H. Wilcox

1993–2025 年に発表

別表記
Mark H Wilcox
181
論文数
36,254
被引用数
96
h 指数
179
i10 指数

被引用数

Mark H. Wilcox の年別被引用数1928 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 4 件1998 年: 被引用 13 件1999 年: 被引用 7 件2000 年: 被引用 14 件2001 年: 被引用 32 件2002 年: 被引用 32 件2003 年: 被引用 35 件2004 年: 被引用 35 件2005 年: 被引用 50 件2006 年: 被引用 71 件2007 年: 被引用 85 件2008 年: 被引用 171 件2009 年: 被引用 148 件2010 年: 被引用 217 件2011 年: 被引用 267 件2012 年: 被引用 336 件2013 年: 被引用 358 件2014 年: 被引用 337 件2015 年: 被引用 339 件2016 年: 被引用 305 件2017 年: 被引用 274 件2018 年: 被引用 307 件2019 年: 被引用 1,254 件2020 年: 被引用 1,102 件2021 年: 被引用 999 件2022 年: 被引用 929 件2023 年: 被引用 608 件2024 年: 被引用 1,010 件2025 年: 被引用 374 件2026 年: 被引用 3 件1929〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,248 件、この内訳の 24.5%イギリス: 引用元論文 1,096 件、この内訳の 12%中国: 引用元論文 457 件、この内訳の 5%カナダ: 引用元論文 415 件、この内訳の 4.5%オーストラリア: 引用元論文 370 件、この内訳の 4%ドイツ: 引用元論文 369 件、この内訳の 4%フランス: 引用元論文 363 件、この内訳の 4%イタリア: 引用元論文 330 件、この内訳の 3.6%オランダ: 引用元論文 264 件、この内訳の 2.9%スペイン: 引用元論文 243 件、この内訳の 2.7%スイス: 引用元論文 205 件、この内訳の 2.2%インド: 引用元論文 155 件、この内訳の 1.7%
0%24.5%その他 28.9%

機関

分野

  • Medicine67.9%
  • Biochemistry, Genetics and Molecular Biology16.9%
  • Immunology and Microbiology5.2%
  • Health Professions3.7%
  • Environmental Science1.6%
  • Agricultural and Biological Sciences1.4%
  • その他3.3%

トピック

  • Clostridium difficile and Clostridium perfringens research15.5%
  • Gut microbiota and health5.6%
  • Nosocomial Infections in ICU4.7%
  • Microscopic Colitis4.6%
  • Antimicrobial Resistance in Staphylococcus3.9%
  • Antibiotic Use and Resistance3.8%
  • その他61.9%

共著者

全論文

検索で開く
  1. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

    著者: L. Clifford McDonald, Dale N. Gerding, Stuart Johnson, Johan Bakken, Karen C. Carroll, Susan Coffin, Erik R. Dubberke, Kevin W. Garey, Carolyn V. Gould, Ciaran Kelly, Vivian G. Loo, Julia Shaklee Sammons, Thomas J. Sandora, Mark H. Wilcox - Clinical Infectious Diseases 2017 被引用: 2,652

  2. Clostridium difficile infection

    著者: Wiep Klaas Smits, Dena Lyras, D. Borden Lacy, Mark H. Wilcox, Ed J. Kuijper - Nature Reviews Disease Primers 2016 被引用: 873

  3. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

    著者: Stuart Johnson, Valéry Lavergne, Andrew M Skinner, Anne J Gonzales-Luna, Kevin W. Garey, Ciarán P. Kelly, Mark H. Wilcox - Clinical Infectious Diseases 2021 被引用: 637

  4. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

    著者: Joffrey van Prehn, Elena Reigadas, Erik Vogelzang, Emilio Bouza, Adriana Hristea, Benoît Guéry, Marcela Krůtová, Torbjörn Norén, Franz Allerberger, John Coia, Abraham Goorhuis, Tessel M. van Rossen, Rogier E. Ooijevaar, Karen Burns, Bente Olesen, Sarah Tschudin‐Sutter, Mark H. Wilcox, Maria J. G. T. Vehreschild, Fidelma Fitzpatrick, Ed J. Kuijper - Clinical Microbiology and Infection 2021 被引用: 602

  5. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

    著者: Mark H. Wilcox, Dale N. Gerding, Ian R. Poxton, Ciarán P. Kelly, Richard Nathan, Thomas Birch, Oliver A. Cornely, Galia Rahav, Emilio Bouza, Christine Lee, G. Jenkin, Werner Jensen, You-Sun Kim, Junichi Yoshida, Lori Gabryelski, Alison Pedley, Karen Eves, Robert Tipping, Dalya Güriş, Nicholas A. Kartsonis, Mary-Beth Dorr - New England Journal of Medicine 2017 被引用: 850

  6. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19

    著者: Davey L. Jones, Marcos Quintela‐Baluja, David W. Graham, Alexander Corbishley, James E. McDonald, Shelagh K. Malham, Luke S. Hillary, Thomas R. Connor, William H. Gaze, Inês B. Moura, Mark H. Wilcox, Kata Farkas - The Science of The Total Environment 2020 被引用: 430

  7. Understanding Clostridium difficile Colonization

    著者: Monique J. T. Crobach, Jon J. Vernon, Vivian G. Loo, Ling Yuan Kong, Séverine Péchiné, Mark H. Wilcox, Ed J. Kuijper - Clinical Microbiology Reviews 2018 被引用: 312

  8. Emergence and global spread of epidemic healthcare-associated Clostridium difficile

    著者: Miao He, Fábio Miyajima, Paul Roberts, Louise Ellison, Derek Pickard, Melissa J. Martin, Thomas R. Connor, Simon R. Harris, Derek Fairley, Kathleen B. Bamford, Stephanie d’Arc, John Brazier, Derek Brown, John Coia, Gill Douce, Dale N. Gerding, Heejung Kim, Tse Hsien Koh, Haru Kato, Mitsutoshi Senoh, Tom Louie, Stephen Michell, Emma Butt, Sharon J. Peacock, Nick M Brown, Tom Riley, G. Songer, Mark H. Wilcox, Munir Pirmohamed, Ed J. Kuijper, Peter M. Hawkey, Brendan W. Wren, Gordon Dougan, Julian Parkhill, Trevor D. Lawley - Nature Genetics 2012 被引用: 740

  9. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection

    著者: Monique J. T. Crobach, Tim Planche, Catherine Eckert, Frédéric Barbut, Elisabeth M. Terveer, Olaf M. Dekkers, Mark H. Wilcox, Ed J. Kuijper - Clinical Microbiology and Infection 2016 被引用: 588

  10. Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe

    著者: Martin Hunt, Phelim Bradley, Simon Grandjean Lapierre, S Heys, Mark Thomsit, Michael B. Hall, Kerri M. Malone, Penelope Wintringer, A Sarah Walker, Daniela María Cirillo, Iñaki Comas, Maha Farhat, Philip W. Fowler, Jennifer L. Gardy, Nazir Ismail, Thomas A. Kohl, Vanessa Mathys, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Vitali Sintchenko, Grace Smith, Dick van Soolingen, Philip Supply, Sabira Tahseen, Mark H. Wilcox, Irena Arandjelović, Tim E. A. Peto, Derrick W. Crook, Zamin Iqbal - Wellcome Open Research 2019 被引用: 203

  11. epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England

    著者: Heather Loveday, Jennie Wilson, Robert Pratt, Mana Golsorkhi, Alison Tingle, Aggie Bak, J. Browne, Jacqui Prieto, Mark H. Wilcox - Journal of Hospital Infection 2013 被引用: 1,612

  12. SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)

    著者: Sahil Khanna, Matthew Sims, Thomas Louie, Monika Fischer, Kerry L. LaPlante, Jessica R. Allegretti, Brooke Hasson, Allyson T. Fonte, Christopher McChalicher, David S. Ege, Jessica A. Bryant, Timothy J. Straub, Christopher B. Ford, Matthew R. Henn, Elaine E. L. Wang, Lisa Von Moltke, Mark H. Wilcox - Antibiotics 2022 被引用: 55

  13. Clostridium difficile infection in Europe: a hospital-based survey

    著者: Martijn P. Bauer, Daan W. Notermans, Birgit HB van Benthem, John Brazier, Mark H. Wilcox, Maja Rupnik, Dominique L. Monnet, Jaap T. van Dissel, Ed J. Kuijper - The Lancet 2010 被引用: 1,019

  14. Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: being AWaRe

    著者: Emma Budd, Emma Cramp, Mike Sharland, Kieran Hand, Philip Howard, Peter Wilson, Mark H. Wilcox, Berit Müller‐Pebody, Susan Hopkins - Journal of Antimicrobial Chemotherapy 2019 被引用: 87

  15. Clostridium difficile infection: new developments in epidemiology and pathogenesis

    著者: Maja Rupnik, Mark H. Wilcox, Dale N. Gerding - Nature Reviews Microbiology 2009 被引用: 1,397

  16. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records

    著者: Karina-Doris Vihta, Nicole Stoesser, Martin Llewelyn, T. Phuong Quan, T. J. Davies, Nicola Fawcett, Laura Dunn, Katie Jeffery, Christopher Butler, Gail Hayward, Monique Andersson, Marcus Morgan, Sarah Oakley, Amy M. Mason, Susan Hopkins, David Wyllie, Derrick W. Crook, Mark H. Wilcox, Alan P. Johnson, Tim Peto, A. Sarah Walker - The Lancet Infectious Diseases 2018 被引用: 173

  17. A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018

    著者: Virginie Viprey, Georgina Davis, Anthony Benson, Duncan Ewin, William Spittal, Jon J. Vernon, Maja Rupnik, Alice Banz, Florence Allantaz, Philippe Cleuziat, the COMBACTE-CDI National Coordinators, Mark H. Wilcox, Kerrie Davies - Eurosurveillance 2022 被引用: 54

  18. Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis

    著者: Christopher Rooney, Kulveer Mankia, Suparna Mitra, Inês B. Moura, Paul Emery, Mark H. Wilcox - Lara D. Veeken 2020 被引用: 49

  19. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile

    著者: Abiola Olumuyiwa Olaitan, Chetna Dureja, Madison A. Youngblom, Madeline A. Topf, Wan‐Jou Shen, Anne J Gonzales-Luna, Aditi Deshpande, Kirk E. Hevener, Jane Freeman, Mark H. Wilcox, Kelli L. Palmer, Kevin W. Garey, Caitlin S. Pepperell, Julian G. Hurdle - Nature Communications 2023 被引用: 56

  20. Multilocus Sequence Typing of Clostridium difficile

    著者: David Griffiths, Warren N. Fawley, Melina Kachrimanidou, Rory Bowden, Derrick W. Crook, Rowena Fung, Tanya Golubchik, Rosalind M. Harding, Katie Jeffery, Keith A. Jolley, Richard Kirton, Tim Peto, Gareth Rees, Nicole Stoesser, Alison Vaughan, A. Sarah Walker, Bernadette Young, Mark H. Wilcox, Kate E. Dingle - Journal of Clinical Microbiology 2009 被引用: 484

  21. An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones

    著者: Maria J. G. T. Vehreschild, Annie Ducher, Thomas Louie, Oliver A. Cornely, Céline Féger, Aaron Dane, Marina Varastet, Fabien Vitry, Jean de Gunzburg, Antoine Andremont, France Mentré, Mark H. Wilcox - Journal of Antimicrobial Chemotherapy 2021 被引用: 48

  22. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection

    著者: Tim Planche, Kerrie Davies, Pietro G. Coen, John Finney, Irene M. Monahan, K. Morris, Lily O’Connor, Sarah Oakley, Cassie F. Pope, M.W.D. Wren, N. P. Shetty, Derrick W. Crook, Mark H. Wilcox - The Lancet Infectious Diseases 2013 被引用: 434

  23. Antibiotic strategies in the era of multidrug resistance

    著者: George H. Karam, Jean Chastre, Mark H. Wilcox, Jean‐Louis Vincent - Critical Care 2016 被引用: 299

  24. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

    著者: Stuart H. Cohen, Dale N. Gerding, Stuart Johnson, Ciarán P. Kelly, Vivian G. Loo, L. Clifford McDonald, Jacques Pepin, Mark H. Wilcox - Infection Control and Hospital Epidemiology 2010 被引用: 2,943